Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

10.4%

5 terminated out of 48 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

15%

7 trials in Phase 3/4

Results Transparency

23%

8 of 35 completed with results

Key Signals

8 with results88% success

Data Visualizations

Phase Distribution

42Total
Not Applicable (25)
Early P 1 (1)
P 1 (3)
P 2 (6)
P 3 (4)
P 4 (3)

Trial Status

Completed35
Terminated5
Withdrawn3
Recruiting2
Not Yet Recruiting1
Unknown1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 35 completed trials

Clinical Trials (48)

Showing 20 of 20 trials
NCT07552779Phase 1Recruiting

A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

NCT04382131Not ApplicableTerminatedPrimary

Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)

NCT04155892CompletedPrimary

Evaluation of Extubation Criteria in Children With Upper Respiratory Infection (URI)

NCT06271655Not ApplicableActive Not Recruiting

Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)

NCT06149494Phase 2Completed

RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection

NCT07085858Not ApplicableNot Yet RecruitingPrimary

Study of the Preventive Effects and Mechanisms of Yeast β-Glucan on Upper Respiratory Tract Infections

NCT05577065Not ApplicableCompletedPrimary

A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children

NCT05955885Early Phase 1Completed

Effect of Over-the-counter NSAIDS on Cough Reflex Sensitivity in Patients with Upper Respiratory Tract Infections

NCT06584461Phase 4CompletedPrimary

Interest of Lidocaine in Children with Upper Airway Infection Undergoing General Anesthesia

NCT05484102Not ApplicableCompletedPrimary

Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children

NCT05804123Not ApplicableCompletedPrimary

LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media

NCT06355661Not ApplicableRecruitingPrimary

A Study for Assessing the Efficacy and Safety ParActin® in Individuals With Upper Respiratory Tract Infections

NCT03463694Not ApplicableCompletedPrimary

Edinburgh and Lothian Virus Intervention Study in Kids

NCT06127186CompletedPrimary

Phenotype of Headache and Facial Pain in Upper Respiratory Tract Infections

NCT05090475Not ApplicableCompletedPrimary

Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health Care

NCT05279534Not ApplicableTerminatedPrimary

Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections

NCT04505098Phase 4Terminated

A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults

NCT05917015Not ApplicableUnknownPrimary

A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers

NCT05557214Not ApplicableWithdrawnPrimary

Reducing Unnecessary Antibiotic Prescriptions in Primary Healthcare in Saskatchewan by Identifying High Prescribers

NCT05252468Not ApplicableCompleted

COVID-19 Prevention Trial: Effect of Prophylactic Use of TAFFIX™ on Infection Rate by SARS-CoV-2 Virus (COVID-19).

Scroll to load more

Research Network

Activity Timeline